Double-blind comparison of bromocriptine and placebo in cocaine withdrawal.
Double-blind comparison of bromocriptine and placebo in cocaine withdrawal.
复制标题
溴隐亭和安慰剂在可卡因戒断中的双盲比较。
DOI:
--
复制
发表时间:
1995
期刊:
影响因子:
--
通讯作者:
Rebecca Lowery
中科院分区:
文献类型:
--
作者:
Kathryn Eiler;M. Schaefer;Daniel Salstrom;Rebecca Lowery
Twenty-nine cocaine-dependent male veterans without other drug dependence completed a double-blind controlled, randomly-assigned study examining the efficacy of bromocriptine versus placebo in the management of cocaine abstinence symptomatology. Serum prolactin (PL) and growth hormone (GH) levels were obtained prior to and after the study was completed. Patients were seen daily and completed several self-report questionnaires, including the Symptom Checklist-90-Revised, the Beck Depression Inventory, and a Cocaine Craving Report. The patients were also asked to rate a variety of cocaine withdrawal symptoms. Overall, there did not appear to be any advantage to receiving bromocriptine versus placebo during the first 3 weeks following cocaine use cessation with the possible exception of changes in activity and appetite level. The placebo group showed a statistically significant increase in activity level during the first week in treatment and a significant increase in appetite throughout the study. Patients in both groups showed significant improvement in the other areas assessed, with improvement appearing to progress according to length of treatment. Hyperprolactinemia or abnormal GH levels were not found in this patient sample as a group. Thirty-four of the original 63 patients dropped out of the study. Seventeen received bromocriptine, and 17 received placebo. There was no significant difference between drug groups in incidence of retaining patients in treatment. The high dropout rate may reflect the difficulty incurred in retaining cocaine-dependent patients in treatment.
DOI:
10.1176/ajp.145.9.1094
发表时间:
1988
期刊:
The American journal of psychiatry
影响因子:
--
作者:
Mendelson,JH;Teoh,SK;Lange,U;Mello,NK;Weiss,R;Skupny,A;Ellingboe,J
通讯作者:
Ellingboe,J
影响因子:
56.9
作者:
GOEDERS, NE;SMITH, JE
通讯作者:
SMITH, JE